Aza-Epoxid-Guaian-Derivate und Krebsbehandlung
EP3102581
Art B1
2. Mai 2018
Anmelder: The United States of America, as represented by The Secretary, Department of Health & Human Services, University of Hawaii, The U.S.A. as represented by the Secretary, Department of Health and Human Services, The University of Hawaii 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP3102581
- Aktenzeichen
- EP15705869
- Anmeldetag
- 5. Februar 2015
- Veröffentlichung
- 2. Mai 2018
- Erteilung
- 2. Mai 2018
- Rechtsraum
- EP
- IPC
- C07D493/08A61K31/352A61P35/00A61P3/00A61P31/00A61P9/00
Abstract
Für dieses Patent liegt uns kein Abstract vor.
Anmelder
- Firmen
- The United States of America, as represented by The Secretary, Department of Health & Human Services
University of Hawaii
The U.S.A. as represented by the Secretary, Department of Health and Human Services
The University of Hawaii - Land
- 🇺🇸 USA
🇺🇸
The U.S.A. as represented by the Secretary, Department of Health and Human Services
US-Bundesbehörde, unter deren Namen Forschungseinrichtungen wie die National Institutes of Health zahlreiche medizinische Patente anmelden. Kein Unternehmen im engeren Sinn, sondern eine Regierungsstelle.
605 Patente in unserer Datenbank